Preprint · CC-BY
via OpenAlex
Liver steatosis and nonalcoholic fatty liver disease with fibrosis are predictors of frailty in people living with HIV
Jovana Milić, Valentina Menozzi, Filippo Schepis, Andrea Malagoli, Giulia Besutti, Iacopo Franconi, Alessandro Raimondi, Federica Carli, Cristina Mussini, Giada Sebastiani, Giovanni Guaraldi
AIDS · 2020 · ▲ 23 citations
Abstract
OBJECTIVE: The aim was to investigate the contribution of liver steatosis and significant fibrosis alone and in association [nonalcoholic fatty liver disease (NAFLD) with fibrosis] to frailty as a measure of biological age in people living with HIV (PLWH). DESIGN: This was a cross-sectional study of consecutive patients attending Modena HIV Metabolic Clinic in 2018-2019. METHODS: Patients with hazardous alcohol intake and viral hepatitis coinfection were excluded. Liver steatosis was diagnosed by controlled attenuation parameter (CAP), while liver fibrosis was diagnosed by liver stiffness measurement (LSM). NAFLD was defined as presence of liver steatosis (CAP ≥248 dB/m), while significant liver fibrosis or cirrhosis (stage ≥F2) as LSM at least 7.1 kPa. Frailty was assessed using a 36-Item frailty index. Logistic regression was used to explore predictors of frailty using steatosis and fibrosis as covariates. RESULTS: We analysed 707 PLWH (mean age 53.5 years, 76.2% men, median CD4 cell count 700 cells/μl, 98.7% with undetectable HIV RNA). NAFLD with fibrosis was present in 10.2%; 18.9 and 3.9% of patients were classified as frail and most-frail, respectively. Univariate analysis demonstrated that neurocognitive impairment [odds ratio (OR) = 5.1, 1.6-15], vitamin D insufficiency (OR = 1.94, 1.2-3.2), obesity (OR = 8.1, 4.4-14.6), diabetes (OR = 3.2, 1.9-5.6), metabolic syndrome (OR = 2.41, 1.47-3.95) and osteoporosis (OR = 0.37, 0.16-0.76) were significantly associated with NAFLD with fibrosis. Predictors of frailty index included steatosis (OR = 2.1, 1.3-3.5), fibrosis (OR = 2, 1-3.7), NAFLD with fibrosis (OR = 9.2, 5.2-16.8), diabetes (OR = 1.7, 1-2.7) and multimorbidity (OR = 2.5, 1.5-4). CONCLUSION: Liver steatosis and NAFLD with fibrosis were associated with frailty. NAFLD with fibrosis exceeded multimorbidity in the prediction of frailty, suggesting the former as an indicator of metabolic age in PLWH.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1097/qad.0000000000002650
- Canonical
- link ↗
- Fetched
- 2026-10-15 MST
Cite this
APA
Milić, J., Menozzi, V., Schepis, F., Malagoli, A., Besutti, G., Franconi, I., Raimondi, A., Carli, F., Mussini, C., Sebastiani, G., & Guaraldi, G. (2020). Liver steatosis and nonalcoholic fatty liver disease with fibrosis are predictors of frailty in people living with HIV. <em>AIDS</em>. https://doi.org/10.1097/qad.0000000000002650
Vancouver
Milić J, Menozzi V, Schepis F, Malagoli A, Besutti G, Franconi I, et al. Liver steatosis and nonalcoholic fatty liver disease with fibrosis are predictors of frailty in people living with HIV. AIDS. 2020. doi:10.1097/qad.0000000000002650.
BibTeX
@unpublished{jovana2020Livers,
title = {Liver steatosis and nonalcoholic fatty liver disease with fibrosis are predictors of frailty in people living with HIV},
author = {Jovana Milić and Valentina Menozzi and Filippo Schepis and Andrea Malagoli and Giulia Besutti and Iacopo Franconi and Alessandro Raimondi and Federica Carli and Cristina Mussini and Giada Sebastiani and Giovanni Guaraldi},
journal = {AIDS},
year = {2020},
doi = {10.1097/qad.0000000000002650},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Diabetes Care 2011
Open access · CC-BY
Prevalence of and Risk Factors for Hepatic Steatosis and Nonalcoholic Fatty Liver Disease in People With Type 2 Diabetes: the Edinburgh Type 2 Diabetes Study
PLoS ONE 2019
Open access · CC-BY
The dynamic association between Frailty, CD4 and CD4/CD8 ratio in people aging with HIV
PubMed 2009
Preprint
Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus.
World Journal of Gastroenterology 2008
Open access · CC-BY
Prevalence of metabolic syndrome, obesity and diabetes type 2 in cryptogenic cirrhosis
Hepatology 2003
Open access · OA
Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference
Indian Journal of Endocrinology and Metabolism 2018
Open access · CC-BY